Team and Management
Dr. Racheli Kreisberg is the CEO and founder of IBEXPERTS Ltd.
She is an entrepreneur who specializes in carrying out ambitious, large-scale international projects.
She has 20 years of proven experience in managing international R&D projects and technology transfer initiatives within the EU.
Prior to founding IBEX, she managed the Bioinformatics Unit of Tel Aviv
She has a Ph.D. in biology from Tel Aviv University, a M.Sc. in chemistry from the Technion and an
MBA from Tel Aviv University. A native of The Netherlands, she speaks English, Dutch, Hebrew,
and moderate German.
Dr. Vincent Collins has more than 20 years of
experience of scientific research, management, and development in the academic, industrial, and
governmental sectors in Europe, North America and Australia. He has published more than 30
peer-reviewed articles in scientific journals and has experience of organizing, writing and
managing national- and EU-funded research projects in the Life and Health Sciences. Over the past
8 years, he has been involved in the evaluation of FP6 and FP7 proposals, as well as in the
auditing of projects and ethical screening of proposals for the Research Executive Agency in
Brussels. Currently, he specializes in developing research and training programs that involve
industrial and academic partners and in the exploitation of innovative research. Vincent holds a
BSc degree in Industrial Microbiology and Chemistry from University College Dublin, Ireland, a
Master degree in Bacterial Genetics from the University of Calgary, Canada, and a PhD in
Microbiology/Vaccinology from the University of Adelaide, Australia. He was born in Ireland and
speaks Gaelic, English, French, and Swedish.
IBEX Company Culture
IBEX is named after a wild goat found in mountainous terrain. It is very agile in
manoeuvering steep cliffs, is well adapted to minimalist conditions, stands on
very strong legs and
possesses an acute sense of hearing.
The IBEX team uses these same characteristics to offer its clients agility, market adaptability and
strategic vision to enhance the R&D capabilities and profitability of an organization.